There are few studies conducted in RA regarding the Th22 subpopulation; nevertheless, its characteristic cytokine, IL-22, which can also be produced by pathogenic Th17, has shown to have a pathogenic role associated with disease activity in RA, promoting osteoclastogenesis and bone destruction in RA [32]. This evidence concerns the gene IL22 and rheumatoid arthritis.